Hyundai Bioscience Co

Hyundai Bioscience Co Interest Coverage

The Interest Coverage Ratio of Hyundai Bioscience Co (048410.KQ) as of Nov 3, 2026 is 0.10. In the previous year, Interest Coverage Ratio was -93.90 — a change of -100.11% (higher).

Interest Coverage

0.10

YoY

-100.11%

Last updated:

Interest Coverage Ratio of Hyundai Bioscience Co is 2024 0.10 . Interest Coverage Ratio of Hyundai Bioscience Co was 2023 -93.90 . It decreases by -100.11% higher compared to the previous year.

The Hyundai Bioscience Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
0.83 KRW
Jan 1, 2018
10.85 KRW
Jan 1, 2019
2.34 KRW
Jan 1, 2020
-201.36 KRW
Jan 1, 2021
-6.58 KRW
Jan 1, 2022
-11.87 KRW
Jan 1, 2023
-93.90 KRW
Jan 1, 2024
0.10 KRW
The Hyundai Bioscience Co Interest Coverage history
YEARInterest CoverageYoY
0.10-100.11%
-93.90+690.98%
-11.87+80.31%
-6.58-96.73%
-201.36-8,697.19%
2.34-78.42%
10.85+1,205.12%
0.83-114.00%
-5.94-260.84%
3.69+350.21%
0.82—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyundai Bioscience Co Stock analysis

What does Hyundai Bioscience Co do? Hyundai Bioscience Co., Ltd. generates revenue through the manufacturing and sale of bio-cosmetics and hair tonics, including functional daily necessities like shampoos, mask packs, and creams. The company also develops tumor-targeted drugs and sells LCD monitors and digital signage display products. Domestic and overseas markets, including Europe, America, and Japan, purchase these products, with the firm distributing its offerings across these regions. The company's product portfolio features bio-cosmetics, hair tonics, shampoos, mask packs, creams, tumor-targeted drugs, LCD monitors, and digital signage displays. These items are sold to customers in both domestic and international markets, with Europe, America, and Japan representing key overseas segments. The firm focuses on functional daily necessities and display technology products as its core revenue streams. Hyundai Bioscience Co., Ltd. targets consumers seeking bio-based personal care products and businesses requiring display solutions. Its domestic market serves local customers, while international segments in Europe, America, and Japan drive global sales. The company’s revenue model combines consumer goods sales with technology-oriented product distribution. Hyundai Bioscience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyundai Bioscience Co stock

Interest Coverage Ratio of Hyundai Bioscience Co is 0.10 in 2024.

Interest Coverage Ratio of Hyundai Bioscience Co changed from -93.90 to 0.10, representing a -100.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Hyundai Bioscience Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Hyundai Bioscience Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hyundai Bioscience Co

All Key Metrics — Hyundai Bioscience Co